News | Breast Density | May 06, 2019

“Margie’s law” requires healthcare facilities to notify patient if dense tissue is detected

Georgia Becomes 38th State With Breast Density Inform Law

May 6, 2019 — Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective July 1, 2019, makes Georgia the 38th state to require healthcare facilities conducting mammograms to provide some form of notification about breast density to patients and referring healthcare providers.

House Bill 62, also known as “Margie’s law,” was introduced through a grassroots advocacy effort led by Margie Singleton, of Savannah, Ga. Singleton was diagnosed with a breast cancer that was missed by screening mammography because she has dense breast tissue.

“I applaud Margie Singleton and the many dedicated advocates and legislators who worked to turn this law into a reality,” said JoAnn Pushkin, executive director of DenseBreast-info.org. “With its passage, over 90 percent of American women now receive some form of communication about breast density after their mammograms. This information will result in more informed discussions with their health care providers about whether supplemental screening might be beneficial.”

At this time, there are no states with pending density inform legislation. The District of Columbia received congressional approval for its law in March 2019.

Proposed changes to the Mammography Quality Standards Act (MQSA) that would establish national minimal standards for breast density notification were issued by the U.S. Food and Drug Administration on March 28, 2019 in the form of an amendment. DB-I is analyzing the proposed language and will be submitting comments to the FDA during the designated “open for public comment” period which concludes June 26, 2019. The final amendment will be published following review of the comments and it will become effective eighteen months following approval. Once the new standard is introduced, it is expected that individual state law review will be necessary.

DenseBreast-Info.org features a U.S. map showing the status of breast density inform legislation in every state.

Watch the VIDEO: A Discussion on Proposed FDA Rules for Mammography Reporting, chief scientific advisor to DenseBreast-Info.org at the 2019 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium.

For more information: www.densebreast-info.org


Related Content

News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
Subscribe Now